îæ€çŽ¢
îæ€çŽ¢
î
BioLine RX Ltd
BLRXîãŠã©ãããªã¹ãã«è¿œå
2.820USD
+0.100+3.72%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
12.27Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
詳现æ å ± BioLine RX Ltd äŒæ¥å
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãBLRX
äŒç€ŸåBioLine RX Ltd
äžå Žæ¥Jan 30, 2007
æé«çµå¶è²¬ä»»è
ãCEOãSerlin (Philip Adam)
åŸæ¥å¡æ°28
蚌åžçš®é¡Depository Receipt
決ç®ææ«Jan 30
æ¬ç€Ÿæåšå°Modi'in Technology Park
éœåžMODIIN
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·7177871
é»è©±çªå·97286429100
ãŠã§ããµã€ãhttps://www.biolinerx.com/
äŒæ¥ã³ãŒãBLRX
äžå Žæ¥Jan 30, 2007
æé«çµå¶è²¬ä»»è
ãCEOãSerlin (Philip Adam)
BioLine RX Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
ãããã質å
BioLine RX Ltdã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îBioLine RX Ltdã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Aharon Schwartz, Ph.D.
BioLine RX LtdïŒBLRXïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãBioLine RX Ltdã®æ ªåŒãä¿æããŠããæ©é¢ã¯60瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ46.33Kã§ãå
šäœã®1.06%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-104547.00å¢å ããŠããŸãã